Bushra Rahman

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers

David L. Elion, Max E. Jacobson, Donna J. Hicks et al. · Cancer Research · 2018 · 179 citations

Medicine, Immunology, Oncology +16

Subacromial balloon spacer for irreparable rotator cuff tears of the shoulder (START:REACTS): a group-sequential, double-blind, multicentre randomised controlled trial

Andrew Metcalfe, Helen Parsons, Jaclyn Brown et al. · The Lancet · 2022 · 114 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +11

Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1

Thomas A. Werfel, David L. Elion, Bushra Rahman et al. · Cancer Research · 2018 · 90 citations · Full text

Life Sciences, Immunology, Oncology +17

Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury

Ehtesham Arif, Ashish K. Solanki, Pankaj Srivastava et al. · Kidney International · 2019 · 68 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

Benjamin A. Fisher, Tonny Veenith, Daniel Slade et al. · UCL Discovery (University College London) · 2022 · 58 citations

Medicine, Internal Medicine, Pharmacotherapy +7